ENTB-FOLLOWS-BMSN! SUBSIDIARY,DIRECTLY RELATED IN VALUE!~
Historically ENTB has followed BMSN around 70% of the value or so,
BMSN JUST GOT CLINICAL TRIAL PROCEDURE APPROVAL, AND MANUFACTURING APPROVAL. THE FDA ONLY REQUESTED **CLARIFICATION** ON SUBMISSIONS ALREADY FINISHED FOR SAFETY.
This medicine has 100% safety, 100% no chance of rejection being as it is specifically tailored to each unique individual.
ONCE THE CLARIFICATION ON THE DOCUMENTS ARE COMPLETE; FULL CLINICAL APPROVAL IS A SURE THING!!
If BMSN goes down, so too should the value of ENTB,
If ENTB goes up, It will be a direct result of BMSN going up.
GLTA, Glad I could clarify.
SINCE ENTB IS OWNED BY DR. KOOS, AND KOOS OWNS BMSN AND ENTB,
ENTB IS OWNED BY BMSN, JUST SAYIN'.
ALL IMHO.
Everything I say is an opinion. Past or future do not base financial decisions off of my posts.
